Medical treatment of advanced esophageal cancer / 国际肿瘤学杂志
Journal of International Oncology
; (12): 286-289, 2010.
Article
en Zh
| WPRIM
| ID: wpr-388566
Biblioteca responsable:
WPRO
ABSTRACT
Cisplatin in combination with fluorouracil still is considered as the basic therapeutic scheme for advanced esophageal cancer. New cytotoxic drugs, such as taxanes and topoisomerase inhibitor etc, and new regimens are focus researches for medical treatment. Intravenous fluorouracil can be replaced by oral fluorouracil derivative, and cisplatin can be replaced by oxaliplatin in the regimens of contained cisplatin and fluorouracil for advanced esophageal cancer. Patients with advanced esophageal cancer are now offered seconded line treatment, and the number of research protocols is increasing. Molecule targeted therapy as a promising treatment will provide more and better options for patients.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Guideline
Idioma:
Zh
Revista:
Journal of International Oncology
Año:
2010
Tipo del documento:
Article